首页> 外文期刊>International journal of colorectal disease. >Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin.
【24h】

Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin.

机译:Lgr5在人类大肠癌发生中的表达及其与β-catenin的潜在相关性。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUNDS AND AIMS: Lgr5 is a member of the G protein receptor super-family and was shown recently to be a stem cell marker for cells with intestinal differentiation. Its over-expression has been demonstrated in hepatocellular, basal cell carcinoma, and ovarian cancers but the underlying mechanisms are poorly understood. The aim of this study was to investigate if Lgr5 over-expression was correlated with human colorectal carcinogenesis and its potential correlation with beta-catenin. METHODS: The study was carried out on a tissue microarray that consisted of 102 colorectal carcinomas (CRC; M:F = 55:47), 18 colon adenoma, and 12 colon normal mucosa cases. Immunostains were performed with the standard EnVision method with primary antibodies against Lgr5, beta-catenin, and p53 antigens. Immunoreactivity of neoplastic cells to each antibody was double-blindly semi-quantified by two pathologists and the data were analyzed with the Chi-square and Spearman rank correlation tests. Subsequently, expression of Lgr5 in tissue sections of tumor centre and invasive margins of 21 cases of CRC certified to be immunoreactive of Lgr5 in TMA were evaluated and possible differences of Lgr5 expression between them were analyzed. RESULTS: Lgr5 immunoreactivity was observed only in single cells in the base of normal colon mucosal crypts but high in 28% (five out of 18) adenomas, and significantly higher in 54% (55/102, p = 0.016) CRC cases. In normal mucosa, adenoma, and CRC, beta-catenin expression was seen in 25% (three out of 12), 27% (five out of 18), and 81% (83/102) cases, respectively, in contrast to 0, 0, and 40% (41/102) for p53 expression, respectively. In CRC, Lgr5 expression was more intense in women than men (p < 0.0001), and positively correlated with beta-catenin expression (p < 0.001), but not with patients' ages, tumor sizes, nodal status, TNM stages, and p53 expression. Different expression of Lgr5 between tumor centre and invasive margins was not found (p > 0.05). CONCLUSIONS: The results suggest that up-regulation of Lgr5 expression, especially in female patients, may play an important role in colorectal carcinogenesis, probably through the WNT/beta-catenin pathway, but not involve the progression of the CRC.
机译:背景与目的:Lgr5是G蛋白受体超家族的成员,最近被证明是具有肠道分化作用的细胞的干细胞标志物。它的过度表达已在肝细胞癌,基底细胞癌和卵巢癌中得到证实,但其潜在机制尚不清楚。这项研究的目的是调查Lgr5的过度表达是否与人类大肠癌的发生及其与β-catenin的潜在关系有关。方法:本研究是在由102例结直肠癌(CRC; M:F = 55:47),18例结肠腺瘤和12例结肠正常黏膜病例组成的组织芯片上进行的。用标准的EnVision方法对Lgr5,β-catenin和p53抗原的一抗进行免疫染色。两名病理学家对肿瘤细胞对每种抗体的免疫反应性进行了双盲半定量,并通过卡方检验和斯皮尔曼等级相关检验对数据进行了分析。随后,评估了21例经TMA证实具有Lgr5免疫反应性的CRC肿瘤中心组织切片中Lgr5的表达和侵袭性边缘,并分析了它们之间的Lgr5表达可能存在差异。结果:仅在正常结肠粘膜隐窝底部的单个细胞中观察到Lgr5免疫反应性,但在28%(18个中的5个)腺瘤中较高,在54%(55/102,p = 0.016)的CRC病例中明显更高。在正常的粘膜,腺瘤和CRC中,分别有25%(12名中的3名),27%(18名中的5名)和81%(83/102)的患者看到了β-catenin的表达,与之相比,0 ,p53表达分别为0和40%(41/102)。在CRC中,女性的Lgr5表达要比男性高(p <0.0001),并且与β-catenin表达呈正相关(p <0.001),但与患者的年龄,肿瘤大小,淋巴结状态,TNM分期和p53无关。表达。未发现肿瘤中心和浸润边缘之间Lgr5的不同表达(p> 0.05)。结论:结果提示Lgr5表达的上调,特别是在女性患者中,可能通过WNT /β-catenin途径在结直肠癌发生中起重要作用,但不涉及CRC的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号